| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ProMIS Neurosciences Inc. | Chief Development Officer | Common Shares | 3,941 | $60,494 | $15.35 | 19 Feb 2026 | Direct |
| ProMIS Neurosciences Inc. | Chief Development Officer | Option (right to buy) | 165,000 | 22 Sep 2025 | Direct | ||
| ProMIS Neurosciences Inc. | Chief Development Officer | Warrants to purchase Common Shares | 2,060 | 03 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PMN | ProMIS Neurosciences Inc. | 19 Feb 2026 | 1 | +$25,005 | 4 | Chief Development Officer | 23 Feb 2026, 08:31 |
| PMN | ProMIS Neurosciences Inc. | 03 Feb 2026 | 2 | +$24,988 | 4 | Chief Development Officer | 05 Feb 2026, 20:40 |
| PMN | ProMIS Neurosciences Inc. | 22 Sep 2025 | 1 | $0 | 4 | Chief Development Officer | 24 Sep 2025, 08:48 |
| PMN | ProMIS Neurosciences Inc. | 18 Nov 2024 | 1 | $0 | 4 | Chief Development Officer | 20 Nov 2024, 19:03 |
| PMN | ProMIS Neurosciences Inc. | 26 Oct 2023 | 1 | $0 | 4 | Chief Development Officer | 30 Oct 2023, 19:46 |
| PMN | ProMIS Neurosciences Inc. | 08 Mar 2023 | 0 | $0 | 3 | Chief Development Officer | 16 Mar 2023, 16:28 |